Ciprofibrate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09064 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 67 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hyperlipoproteinemia | KG + DL |
| 2 | cholesterol-ester transfer protein deficiency | KG + DL |
| 3 | hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | KG + DL |
| 4 | hyperlipidemia due to hepatic triglyceride lipase deficiency | KG + DL |
| 5 | familial hypercholesterolemia | KG + DL |
| 6 | hyperlipidemia | KG + DL |
| 7 | homozygous familial hypercholesterolemia | KG + DL |
| 8 | familial hyperlipidemia | KG + DL |
| 9 | fibroma of prostate | KG + DL |
| 10 | prostate cancer/brain cancer susceptibility | KG + DL |
| 11 | benign reproductive system neoplasm | KG + DL |
| 12 | Brenner tumor | KG + DL |
| 13 | benign prostate phyllodes tumor | KG + DL |
| 14 | male reproductive organ cancer | KG + DL |
| 15 | hypercholesterolemia, autosomal dominant | KG + DL |
| 16 | primary release disorder of platelets | KG + DL |
| 17 | pseudo-von Willebrand disease | KG + DL |
| 18 | prostate leiomyoma | KG + DL |
| 19 | HIV infectious disease | KG + DL |
| 20 | Glanzmann thrombasthenia | KG + DL |
| 21 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 22 | hyperalphalipoproteinemia | KG + DL |
| 23 | simian immunodeficiency virus infection | KG + DL |
| 24 | feline acquired immunodeficiency syndrome | KG + DL |
| 25 | hypertriglyceridemia, familial | KG + DL |
| 26 | familial hypobetalipoproteinemia | KG + DL |
| 27 | prostate neoplasm | KG + DL |
| 28 | familial chylomicronemia syndrome | KG + DL |
| 29 | primary hyperoxaluria | KG + DL |
| 30 | bone Paget disease | KG + DL |
| 31 | hypolipoproteinemia (disease) | KG + DL |
| 32 | dense granule disease | KG + DL |
| 33 | marcothrombocytopenia with mitral valve insufficiency | KG + DL |
| 34 | retinal telangiectasia | KG + DL |
| 35 | hereditary thrombocytopenia with normal platelets | KG + DL |
| 36 | transient neonatal thrombocytopenia | KG + DL |
| 37 | retinal artery occlusion | KG + DL |
| 38 | retinal microaneurysm | KG + DL |
| 39 | arteriosclerotic retinopathy | KG + DL |
| 40 | vertebral artery occlusion | KG + DL |
| 41 | benign mammary dysplasia | KG + DL |
| 42 | breast fibrocystic disease | KG + DL |
| 43 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 44 | hepatopulmonary syndrome | KG + DL |
| 45 | hepatoportal sclerosis | KG + DL |
| 46 | primitive portal vein thrombosis | KG + DL |
| 47 | idiopathic copper-associated cirrhosis | KG + DL |
| 48 | thrombocytopenia | KG + DL |
| 49 | hepatic porphyria | KG + DL |
| 50 | apocrine adenosis of breast | KG + DL |
(Showing top 50 of 67 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.